Red blood cell glutathione levels in lung cancer patients treated by radiation and continuously infused carboplatin

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 1033-1038

  Groen, H J M ^a   Meijer, C ^a   De Vries, E G E ^a   Mulder, N H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chemotherapy; Combined treatment; Non small cell lung cancer; Radiotherapy; Red blood cell glutathione level

Indexed keywords

CARBOPLATIN; CISPLATIN; GLUTATHIONE;

ARTICLE; CANCER ADJUVANT THERAPY; CELL FREE SYSTEM; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ERYTHROCYTE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL-FREE SYSTEM; COMBINED MODALITY THERAPY; ERYTHROCYTES; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; PLATINUM; SMOKING;

EID: 0030010762     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Dillman RO, Seagren SL, Propert KJ et al: A randomised trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323: 940-945, 1990.
2. Schaake-Koning C, Van Den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524-530, 1992.
3. Bump EA and Brown JM: Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. Pharmacol Ther 47: 117-136, 1990.
4. Meijer C, Mulder NH and De Vries EGE: The role of detoxifying systems in resistance of tumour cells to cisplatin and adriamycin. Cancer Treat Rev 17: 389-407, 1990.
5. Sies H and Ketterer B: Glutathione conjugation: mechanisms and biological significance. London, Academic Press, 1989.
6. Ziegler DM: Role of reversible oxidation-reduction of enzyme thiols-disulphides in metabolic regulation. Ann Rev Biochem 53: 305-329, 1985.
7. Meijer C, Mulder NH, Hospers GAP et al. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 62: 72-77, 1990.
8. Saburi Y, Nakagawa M, Ono M et al: Increased expression of glutathione s-transferase gene in cisdiamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. Cancer Res 49: 7020-7025, 1989.
9. Teicher BA, Holden SA, Kelley MJ et al: Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum (II). Cancer Res 47: 388-393, 1987.
10. Waxman DI: Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy. A review. Cancer Res 50: 449-6454, 1990.
11. Campling BG, Baer K, Baker HM et al: Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines? Br J Cancer 68: 327-335, 1993.
12. Carmichel J, Mitchell JB, Friedman N et al: Glutathione and related enzyme activity in human lung cancer cell lines. Br J Cancer 58: 437-440, 1988.
13. Morstyn G, Russo A, Carney DN et al: Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell lines. J Natl Cancer Inst 73: 801-807, 1984.
14. Mitchell JB and Russo A: The role of glutathione in radiation and drug induced cytotoxicity. Br J Cancer 55: 96-104, 1987.
15. Dedon PC and Borch RF: Characterization of the reactions of platinum antitumor agents with biological and nonbiological sulphur-containing nucleophiles. Biochem Pharm 12: 1955-1964, 1987.
16. Eastman A: Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum co-ordination complexes. Chem Biol Interactions 61: 241, 1987.
17. Ishikawa T and Ali-Osman F: Glutathione-associated cisdiammine-dichloro-platinum(II) metabolism and ATP-dependent efflux from leukaemia cells. J Biol Chem 268: 20115-20125, 1993.
18. Ward JF: Molecular mechanisms of radiation-induced damage to nucleic acids. Adv Radiat Biol 5: 181-239, 1975.
19. Hercbergs A, Brok-Simoni F, Holtzman F et al: Erythrocyte glutathione and tumor response to chemotherapy. Lancet 339: 1074-1076, 1992.
20. WHO Handbook for Reporting Results of Cancer Treatment. WHO ofset Publication no 48, Nijhoff Den Haag. The Netherlands, 1978.
21. Tietze F: Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27: 502-522, 1969.
22. Berners-Price SJ and Kuchel PW: Reaction of cis- and trans-[PtC12(NH3)2] with reduced glutathione inside human red blood cells, studied by 1H and 15N-[1H] DEPT NMR. J Inorg Biochem 38: 327-345, 1990.
23. Shaw JP and Chou IN: Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts. J Cell Physiol 129: 193-198, 1986.
24. Smaaland R, Svardal AM, Lote K et al: Glutathione content in human bone marrow and circadian stage relation to DNA synthesis. J Natl Cancer Inst 83: 11092-10198, 1991.
25. Hagenfeldt L, Arvidsson A and Larsson A: Glutathione and g-glutamylcysteine in whole blood, plasma and erythrocytes. Clin Chim Acta 85: 167-173, 1978.
26. Griffith Ow Glutathione turnover in human erythrocytes. Inhibition by buthionine sulphoximine and incorporation of glycine by exchange. J Biol Chem 256: 4900-4904, 1981.
27. Arrick BA and Nathan CF: Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res 96: 4224-4232, 1984.
28. Biaglow JE, Varnes ME, Clark EP et al: The role of thiols in cellular response to radiation and drugs. Radiat Res 95: 437-455, 1983.
29. Mitchell JB, Russo A, Biaglow JE et al: Cellular glutathione depletion by diethyl malcäte or buthionine sulphoximine: no effect of glutathione depletion on the oxygen enhancement ratio. Radiat Res 96: 422-428, 1983.
30. Cole SPC, Downes HF, Mirski SELK et al: Alterations in glutathione and glutathionerelated enzymes in a multidrug resistant small cell lung cancer cell line. Mol Pharmacol .17: 192-197, 1990.
31. Hospers GAP, Mulder NH, De Jong Br et al: Characterization of a human small cell lung carcinoma cell line with acquired resistance to cisdiamminedichloroplatinum (II) in vitro. Cancer Res 48: 16803-6807, 1988.
32. Meijer C, Mulder NH, Timmer-Bosscha H et al: Relationship of cellular glutathione to the cytotoxicity and the resistance of seven platinum compounds. Cancer Res 52: 1588-6889, 1992.
33. Perry RR, Mazetta I, Levin M et al: Glutathione levels and variability in breast tumors and normal tissue. Cancer 72: 783-787, 1993.
34. Cook JA, Pass HI, Iype SN et al: Cellular glutathione and thiol measurements from surgically resected human lung tumour and normal lung tissue. Cancer Res 51: 4287-4294, 1991.
35. Gurtoo HL, Hipkens JH and Sharma SD: Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res 41: 584-3591, 1981.
36. Beutler E and Matsumoto F: Ethnic variations in red cell glutathione peroxidase activity. Blood 46: 103, 1975.
37. Menendez CE, Hacker P, Sonnenfeld M et al: Thyroid hormone control of glutathione reductase activity in rat erythrocytes and liver. Am J Physiol 226: 1480-1483, 1974.
38. Murakami K, Kondo T, Ohtsuka Y et al: Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 8: 753-758, 1989.
39. Frischer H and Ahmad T: Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU [1.3-bis(chloroethyl)-1-nitrosourea]. J Lab Clin Med 9: 1080-1091, 1977.
40. Okuda J, Hirai Y and Hayazaki T: Mechanism of inhibition of erythrocyte glutathione reductase by mitomycine-C. Clin Chim Acta 181: 37-46, 1989.
41. 42t Cantin A, North SL, Hubbard RC et al: Normal alveolar epithelial lining fluids contains high levels of glutathione. J Appl Physiol 63: 152-157, 1987.
42. Toth KM, Berger RE, Beehler EM et al: Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am Rev Respir Dis 134: 81-284, 1986.